marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-03-2022
Codiak BioSciences Balance Sheet 2011-2024 | CDAK
Annual Balance Sheet Codiak BioSciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-39.4 M | -27.4 M | 72.3 M | -18.1 M | - | - | - | - | - | - | - |
Long Term Debt |
34.9 M | 25 M | 9.57 M | - | - | - | - | - | - | - | - |
Long Term Debt Current |
2.66 M | 1.48 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 119 M | 74.3 M | 732 K | - | - | - | - | - | - | - |
Total Current Liabilities |
27.2 M | 17.7 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
118 M | 137 M | 94 M | 5.63 M | - | - | - | - | - | - | - |
Deferred Revenue |
13 M | 5.28 M | 742 K | - | - | - | - | - | - | - | - |
Retained Earnings |
-325 M | -288 M | -193 M | -109 M | - | - | - | - | - | - | - |
Total Assets |
172 M | 151 M | 116 M | 97.7 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
76.9 M | 88.9 M | - | - | - | - | - | - | - | - | - |
Book Value |
53.5 M | 14.6 M | 22 M | 92 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
53.5 M | 14.6 M | -193 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Codiak BioSciences
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 32.6 M | - | 34.1 M | 34.9 M | 34.7 M | 35.3 M | 35.9 M | 36.5 M | 36.5 M | 36.5 M | 36.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 95.5 M | - | 102 M | 118 M | 125 M | 123 M | 123 M | 137 M | 137 M | 137 M | 137 M | 94 M | 94 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | 1.36 M | - | 442 K | 13 M | 9.35 M | 9.12 M | 4.34 M | 5.28 M | 5.28 M | 5.28 M | 5.28 M | 742 K | 742 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | -359 M | - | -333 M | -325 M | -342 M | -320 M | -298 M | -288 M | -288 M | -288 M | -288 M | -193 M | -193 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | 134 M | - | 150 M | 172 M | 159 M | 175 M | 191 M | 151 M | 151 M | 151 M | 151 M | 116 M | 116 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | 51.8 M | - | 56.5 M | 76.9 M | 98.6 M | 114 M | 130 M | 88.9 M | 88.9 M | 88.9 M | 88.9 M | 10.3 M | 10.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | 38.9 M | - | 48.4 M | 53.5 M | 34 M | 51.9 M | 68.7 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 22 M | 22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | 38.9 M | 44.4 M | 48.4 M | 53.5 M | 34 M | 51.9 M | 68.7 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | -193 M | -193 M | -148 M | - | -109 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency